Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064

Expensive Underperformer

Download real time

998.45 1.05 (0.11%)

26.58% Fall from 52W High

419.0K NSE+BSE Volume

NSE 31 Jul, 2025 3:31 PM (IST)

25,417

Market Cap

High in industry

0.5

Beta 1Year

Very Low volatility

Cohance Lifesciences Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for COHANCE, BSE:543064 Cohance Lifesciences Ltd.

VOTE: Is Suven Pharmaceuticals Ltd. worth buying?

26 Votes:

Buy 69.23%

Sell 11.54%

Hold 19.23%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >